tm logo

Monitor this mark

View On USPTO

ADZYNMA
Live/Registered
REGISTERED

on 16 Apr 2024

Last Applicant/ Owned by

Takeda Pharmaceuticals International AG

Thurgauerstrasse 130

Glattpark-Opfikon

CH

8152

Serial Number

97587783 filed on 12th Sep 2022

Registration Number

7358135 registered on 16th Apr 2024

in the Principal Register

Correspondent Address

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq. TROUTMAN PEPPER HAMILTON SANDERS LLP

c/o IP Services

New York, NY 10022

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ADZYNMA

Pharmaceutical preparations, namely, enzyme replacement therapy for thrombotic disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, enzyme replacement therapy for thrombotic disorders

First Use Date in General

28th Nov 2023

First Use Date in Commerce

28th Nov 2023

Mark Details

Serial Number

No 97587783

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 256532000315

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
16th Apr 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
16th Apr 2024REGISTERED-PRINCIPAL REGISTER
30th Jan 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30th Jan 2024PUBLISHED FOR OPPOSITION
10th Jan 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22nd Dec 2023APPROVED FOR PUB - PRINCIPAL REGISTER
22nd Dec 2023EXAMINER'S AMENDMENT ENTERED
22nd Dec 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22nd Dec 2023EXAMINERS AMENDMENT E-MAILED
22nd Dec 2023EXAMINERS AMENDMENT -WRITTEN